- Email: [email protected]
Update on Allergic and Nonallergic Rhinitis
6:30 AM to 7:45 AM LACC Room 152 ⫹ 153ABC Foundation Annual Meeting Symposia (FAMS) •
Update on Allergic and Nonallergic Rhinitis
Robert M Naclerio, MD (Moderator); Fuad M Baroody, MD; Jayant Pinto, MD Chicago IL; Chicago IL; Chicago IL Rhinitis - inflammation of the nasal mucosa, can be classified into allergic (IgE-mediated) and nonallergic forms. These problems affect more than 50 million Amer-
8:00 AM to 9:30 MINISEMINARS
AM
8:00 AM to 9:30 AM LACC Room 515B •
Miniseminar: Complications and Controversies of Snoring Surgery: How to Recognize, Avoid, and Treat
Peter G. Michaelson, MD (Moderator); Eric A Mair, MD; Edward M Weaver, MDMPH; Yosef P Krespi, MD; Samuel A Mickelson, MD; Frank R Miller, MD; Scott E Brietzke, MD, MPH San Antonio TX; San Antonio TX; Seattle WA; New York NY; Atlanta GA; San Antonio TX; North Potomac MD Few conditions are both as prevalent and potentially disturbing as snoring. This unfortunate consequence of sleep continues to affect millions and has been reported to disturb at least 20% of the adult population, nearly 60 million adults. Basically, it is rare to meet an individual either not directly affected by this malady, or not knowing of someone who is; this translates into immense interest by our patients’ in potential treatments. The surgical treatments of snoring and mild obstructive sleep apnea have evolved significantly in recent years. However, while we are constantly bombarded with “new and improved” treatment strategies to diminish snoring and apnea, this topic is not without its controversy: From
P46 Otolaryngology–Head and Neck Surgery
icans, interfere with the quality of life, initiate about 20 million physician visits, and cost the US economy billions of dollars each year. Researchers have investigated the pathophysiology of rhinitis with nasal lavage, scrapings, and biopsies following antigenic and nonantigenic nasal stimulation. Similar studies have been performed during natural disease. Biochemical and cytologic information is relatively easily obtainable, and pharmacologic manipulations can be reliably monitored. The therapy for treatment continues to expand and change. The latest treatment options will be discussed relative to pathophysiology and overall guidelines for management.
lasers to lubricants, somnoplasty to snoreplasty, palatal implants to pillows, GBAT to gee-whiz, and nasal and oral appliances to nasal and oral surgery. Even the very diagnosis of apnea has its share of debate when examining the accuracy of traditional laboratory multichannel polysomnopgraphy to the portable take-home sleep test. However, even potentially more controversial is what to do about the wide-ranging complications we are now experiencing. This miniseminar brings recognized national experts from across the country, airing their dirty laundry to ensure that today’s otolarnygologist is aware and updated on misadventures of snoring surgery. Presented topics include how to recognize, avoid, and treat complications from traditional surgeries that may result in velopharyngeal insufficiency, nasopharyngeal stenosis, postoperative hemorrhage, excessive pain, and airway loss. We will also discuss the specific risks of newer techniques and devices, such as injection snoreplasty, palatal implants and even commercial snoring aids. In addition, attention will be given to the risks and debate surrounding the very diagnosis of apnea itself, from traditional polysomnogram diagnosis to the take-home sleep test. Guidelines and “How I Do It” pearls are presented by the panel to help guide the otolaryngologist in knowing when to cut and when not to cut. Case presentations are discussed with an interactive question and answer session from the audience. A CDRom with complete Power Point presentation and all pertinent publications from the experts is provided to each miniseminar participant. The purpose of this conference is to provide up-to-date, clinically relevant information to
August 2005
MONDAY
Monday, September 26, 2005
Update on Allergic and Nonallergic Rhinitis
Robert M Naclerio, MD (Moderator); Fuad M Baroody, MD; Jayant Pinto, MD Chicago IL; Chicago IL; Chicago IL Rhinitis - inflammation of the nasal mucosa, can be classified into allergic (IgE-mediated) and nonallergic forms. These problems affect more than 50 million Amer-
8:00 AM to 9:30 MINISEMINARS
AM
8:00 AM to 9:30 AM LACC Room 515B •
Miniseminar: Complications and Controversies of Snoring Surgery: How to Recognize, Avoid, and Treat
Peter G. Michaelson, MD (Moderator); Eric A Mair, MD; Edward M Weaver, MDMPH; Yosef P Krespi, MD; Samuel A Mickelson, MD; Frank R Miller, MD; Scott E Brietzke, MD, MPH San Antonio TX; San Antonio TX; Seattle WA; New York NY; Atlanta GA; San Antonio TX; North Potomac MD Few conditions are both as prevalent and potentially disturbing as snoring. This unfortunate consequence of sleep continues to affect millions and has been reported to disturb at least 20% of the adult population, nearly 60 million adults. Basically, it is rare to meet an individual either not directly affected by this malady, or not knowing of someone who is; this translates into immense interest by our patients’ in potential treatments. The surgical treatments of snoring and mild obstructive sleep apnea have evolved significantly in recent years. However, while we are constantly bombarded with “new and improved” treatment strategies to diminish snoring and apnea, this topic is not without its controversy: From
P46 Otolaryngology–Head and Neck Surgery
icans, interfere with the quality of life, initiate about 20 million physician visits, and cost the US economy billions of dollars each year. Researchers have investigated the pathophysiology of rhinitis with nasal lavage, scrapings, and biopsies following antigenic and nonantigenic nasal stimulation. Similar studies have been performed during natural disease. Biochemical and cytologic information is relatively easily obtainable, and pharmacologic manipulations can be reliably monitored. The therapy for treatment continues to expand and change. The latest treatment options will be discussed relative to pathophysiology and overall guidelines for management.
lasers to lubricants, somnoplasty to snoreplasty, palatal implants to pillows, GBAT to gee-whiz, and nasal and oral appliances to nasal and oral surgery. Even the very diagnosis of apnea has its share of debate when examining the accuracy of traditional laboratory multichannel polysomnopgraphy to the portable take-home sleep test. However, even potentially more controversial is what to do about the wide-ranging complications we are now experiencing. This miniseminar brings recognized national experts from across the country, airing their dirty laundry to ensure that today’s otolarnygologist is aware and updated on misadventures of snoring surgery. Presented topics include how to recognize, avoid, and treat complications from traditional surgeries that may result in velopharyngeal insufficiency, nasopharyngeal stenosis, postoperative hemorrhage, excessive pain, and airway loss. We will also discuss the specific risks of newer techniques and devices, such as injection snoreplasty, palatal implants and even commercial snoring aids. In addition, attention will be given to the risks and debate surrounding the very diagnosis of apnea itself, from traditional polysomnogram diagnosis to the take-home sleep test. Guidelines and “How I Do It” pearls are presented by the panel to help guide the otolaryngologist in knowing when to cut and when not to cut. Case presentations are discussed with an interactive question and answer session from the audience. A CDRom with complete Power Point presentation and all pertinent publications from the experts is provided to each miniseminar participant. The purpose of this conference is to provide up-to-date, clinically relevant information to
August 2005
MONDAY
Monday, September 26, 2005